Chemoreactome analysis of 7-hydroxymatairesinol, 17-estradiol, phytoestrogen β-sitosterol and epigallocatechin-3-gallate
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.152
Abstract
The results of the evaluation of 7-hydroximatairesinol (7-HMR) properties in comparison with control molecules (17-estradiol, phytoestrogen β-sytostirol, epigallocatechin-3-gallate) are presented. The results of chemoreactomic modeling allowed to formulate the molecular mechanisms of 7-HMR pharmacological effects for anti-inflammatory (inhibition of 5-lipoxygenase, matrix metalloproteinase MMR2, mitogen-activated kinase p38-alpha, leukotriene-b4 receptor, prostacyclin receptor), antitumor (antioxidant effect due to inhibition of hemoxygenase-2, inhibition of cyclin dependent kinases 3 and 4, epidermis growth factor, protein mTOR), vasodilator (inhibition of adrenoreceptors and renin), antibacterial and antiviral (inhibition of viral proteases 3C) properties of 7-HMR molecule.
Keywords
7-hydroxymatairesinol,
spruce lignans,
17-estradiol,
β-sitosterol phytoestrogen,
epigallocatechin-3-gallate,
chemoreactome analysis
Supporting agencies: This work was funded by the RFBR grant 18-07-00944.
About the Authors
I. Yu. Torshin
Institute of Pharmacoinformatics, Federal Research Center «Informatics and Management», Russian Academy of Sciences;
Big Data Storage and Analysis Center, Lomonosov Moscow State University
Russian Federation
Russian Federation
Ivan Yu. Torshin – PhD (Chemistry), PhD in Applied Mathematics, Senior Researcher, Senior Researcher, Big Data Storage and Analysis Center
42 Vavilova Str., Moscow 119333
1 Leninskie gory, Moscow 119234
Scopus Author ID: 7003300274
Researcher ID: C-7683-2018
Author ID: 54104
WOS ID: C-7683-2018
A. N. Rubashkina
Ivanovo State Medical Academy, Health Ministry of Russian Federation
Russian Federation
Russian Federation
Anna N. Rubashkina – MD, Postgraduate Student, Department of Oncology, Obstetrics and Gynecology
8 Sheremetyevskiy Ave., Ivanovo 153012
N. P. Lapochkina
Ivanovo State Medical Academy, Health Ministry of Russian Federation
Russian Federation
Russian Federation
Nina P. Lapochkina – МD, Dr Sci Med, Associate Professor, Department of Oncology, Obstetrics and Gynecology
8 Sheremetyevskiy Ave., Ivanovo 153012
O. A. Gromova
Institute of Pharmacoinformatics, Federal Research Center «Informatics and Management», Russian Academy of Sciences;
Big Data Storage and Analysis Center, Lomonosov Moscow State University
Russian Federation
Russian Federation
Olga A. Gromova – MD, Dr Sci Med, Professor, Leading Researcher, Scientific Director; Leading Researcher, Big Data Storage and Analysis Center
42 Vavilova Str., Moscow 119333
1 Leninskie gory, Moscow 119234
Scopus Author ID 7003589812
Researcher ID: J-4946-2017
Author ID: 94901
WOS ID: J-4946-2017
References
1. Yang D., Xiao C.X., Su Z.H. et al. (-)-7(S)-hydroxymatairesinol protects against tumor necrosis factor-α-mediated inflammation response in endothelial cells by blocking the MAPK/NF-κB and activating Nrf2/HO-1. Phytomedicine. 2017;32:15–23. DOI: 10.1016/j.phymed.2017.04.005.
2. Gromova O.A., Torshin I.Yu., Rubashkina A.N. et al. Systematic analysis of fundamental and clinical studies of lignan 7-hydroxymatairezinol. [Sistematicheskij analiz fundamental'nyh i klinicheskih issledovanij lignana 7-gidroksimatairezinola]. Effektivnaya farmakoterapiya. 2019;15(13):34–41. (In Russ.). DOI 10.33978/2307-3586-2019-15-13-34-41.
3. Cosentino M., Marino F., Ferrari M. et al. Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignan) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells. Pharmacol Res. 2007;56(2):140–7. DOI: 10.1016/j.phrs.2007.05.001.
4. Torshin I.Yu. Bioinformatics in the post-genomic era: physiology and medicine. NY, USA: Nova Biomedical Books, 2007. 302 р. ISBN: 1-60021-752-4.
5. Torshin I.Yu. Bioinformatics in the post-genomic era: sensing the change from molecular genetics to personalized medicine. NY, USA: Nova Biomedical Books, 2009. 366 р. ISBN: 978-1-60692-217.
6. Zhuravlev Yu.I., Rudakov K.V., Torshin I.Yu. Algebraic criteria for local solvability and regularity as a tool for studying the morphology of amino acid sequences. [Algebraicheskie kriterii lokal'noj razreshimosti i regulyarnosti kak instrument issledovaniya morfologii aminokislotnyh posledovatel'nostej]. Trudy MFTI. 2011;3(4):45–54. (In Russ.).
7. Torshin I.Yu., Rudakov K.V. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 1: fundamentals of modern chemical bonding theory and the concept of the chemograph. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2014;24(1):11–23. DOI: 10.1134/S1054661814010209.
8. Torshin I.Yu. On solvability, regularity, and locality of the problem of genome annotation. Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications). 2010;20(3):386–95. DOI: 10.1134/S1054661810030156.
9. Torshin I.Yu., Gromova O.A. Expert data analysis in molecular pharmacology. [Ekspertnyj analiz dannyh v molekulyarnoj farmakologii]. Moskva: Izd-vo. MCNMO, 2012. 768 s. (In Russ.).
10. Torshin I.Yu., Rudakov K.V. On the procedures of generation of numerical features over partitions of sets of objects in the problem of predicting numerical target variables. Pattern Recognition and Image Analysis. 2019;29(4):654–67. DOI: 10.1134/S1054661819040175.
11. Wishart D.S., Tzur D., Knox C. et al. HMDB: the human metabolome database. Nucleic Acids Res. 2007;35(Database issue):D521–6. DOI: 10.1093/nar/gkl923.
12. Zhang D., Anantharam V., Kanthasamy A., Kanthasamy A.G. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. J Pharmacol Exp Ther. 2007;322(3):913–22. DOI: 10.1124/jpet.107.124669.
13. Goldstein D.M., Gabriel T. Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development. Curr Top Med Chem. 2005;5(10):1017–29. DOI: 10.2174/1568026054985939.
14. Samson K. LEE011 CDK inhibitor showing early promise in drug-resistant cancers. Oncology Times. 2014;36(3):39–40. DOI: 10.1097/01.COT.0000444043.33304.c1.
15. Walker F., Abramowitz L., Benabderrahmane D. et al. Growth factor receptor expression in squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus. Hum Pathol. 2009;40(11):1517–27. DOI: 10.1016/j.humpath.2009.05.010.
16. Liang W., Wu X., Fang W. et al. Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations. PLoS One. 2014;9(2):e85245. DOI: 10.1371/journal.pone.0085245.
17. Xu K., Liu P., Wei W. mTOR signaling in tumorigenesis. Biochim Biophys Acta. 2014;1846(2):638–54. DOI: 10.1016/j.bbcan.2014.10.007.
18. Lamming D.W., Ye L., Sabatini D.M., Baur J.A. Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest. 2013;123(3):980–9. DOI: 10.1172/JCI64099.
19. Desrosiers M.R., Weathers P.J. Effect of leaf digestion and artemisinin solubility for use in oral consumption of dried Artemisia annua leaves to treat malaria. J Ethnopharmacol. 2016;190:313–8. DOI: 10.1016/j.jep.2016.06.041.
20. Saarinen N.M., Wärri A., Mäkelä S.I. et al. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer. 2000;36(2):207–16. DOI: 10.1207/S15327914NC3602_10.
21. Gromova O.A., Rubashkina A.N., Filimonova M.V. et al. Adjuvant therapy with lignan 7-hydroxymatairezinol as a method of increasing the oncological safety of estrogen administration. [Ad"yuvantnaya terapiya lignanom 7-gidroksimatairezinolom kak metod povysheniya onkologicheskoj bezopasnosti priema estrogenov]. Effektivnaya farmakoterapiya. 2018;(13):14–9. (In Russ.).
Review
For citations:
Torshin I.Yu., Rubashkina A.N., Lapochkina N.P., Gromova O.A. Chemoreactome analysis of 7-hydroxymatairesinol, 17-estradiol, phytoestrogen β-sitosterol and epigallocatechin-3-gallate. Obstetrics, Gynecology and Reproduction. 2020;14(3):347-360. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.152
Views:
687
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
